Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ra Pharmaceuticals Inc (NQ: RARX )

47.99 USD UNCHANGED
Last Price Updated: 7:32 PM EDT, Apr 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Ra Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Earnings GRTS IFRX
From Benzinga
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags News FDA IMMP
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday, 3 companies achieved new highs for the year. Points of Interest: Ra Pharmaceuticals(NASDAQ: RARX)was ... 
Tags Movers RARX 52 Week Highs
From Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags LPCN PRNB GSK
From Benzinga
The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags RTTR EXEL EVRC
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 348 companies set new 52-week highs. Noteworthy Mentions: Apple (NASDAQ: AAPL) was the ... 
Tags DAR TGCDF TBK
From Benzinga
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags BIO ARQL ASMB
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Wednesday's morning session saw 173 companies set new 52-week highs. Noteables: Apple (NASDAQ: AAPL) was the company with ... 
Tags IMKTA PCMC MFV
From Benzinga
Is This Small-Cap Biotech a Buy Before 2020?
Stocks of drug developers, particularly small ones, can skyrocket or crater based on late-stage clinical trials. Before year-end, ChemoCentryx may do one or the other. 
Tags CCXI Market News APLS
From Motley Fool
3 Companies to Watch At Kidney Week 2019
Keeping up with the news from major medical meetings has become a requirement for healthcare investors. 
Tags RARX RETA RTRX
From Motley Fool
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags AKBA Top Stories SBBP
From Benzinga
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags AKER JAGX ADPT
From Benzinga
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
With stock valuations down and out, the timing may be ripe for pharma and big biotech companies to start bargain hunting. 
Tags AGN RARX LLY
From Motley Fool
A Look At Benzinga Pro's Most-Searched Tickers For October 11, 2019
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga ... 
Tags SES DAL News
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 11, 2019
Upgrades For Deckers Outdoor Corp (NYSE: DECK), Stifel Nicolaus upgraded the stock from Hold to Buy. In the first quarter, Deckers ... 
Tags PRGO BF/B GSK
From Benzinga
10 Biggest Price Target Changes For Friday
Morgan Stanley lowered Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) price target from $177 to $170. Alexion Pharmaceuticals shares ... 
Tags DECK Analyst Ratings Price Target
From Benzinga
RARX Crosses Above Average Analyst Target
In recent trading, shares of Ra Pharmaceuticals Inc (RARX) have crossed above the average analyst 12-month target price of $43.50, changing hands for $45.64/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
The following is aroundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags REXN VIVO OBLN
From Benzinga
55 Biggest Movers From Yesterday
Gainers Ra Pharmaceuticals, Inc. (NASDAQ: RARX) shares climbed 101.1% to close at $45.64 on Thursday after the company announced ... 
Tags BE SWKS BBBY
From Benzinga
Why Bed Bath & Beyond, Ra Pharmaceuticals, and Freeport-McMoRan Jumped Today
One of these stocks was pushed higher after it revealed who will next sit in the CEO's chair. 
Tags RARX BBBY FCX
From Motley Fool
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: 
Tags companyNews
From Reuters: Company News
Noteworthy Thursday Option Activity: BBBY, RARX, USCR
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Bed, Bath & Beyond, Inc. (BBBY), where a total volume of 115,463 contracts has been... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Ra Pharmaceuticals Surges Following Acquisition News; Forescout Technologies Shares Fall
Toward the end of trading Thursday, the Dow traded up 0.74% to 26,540.26 while the NASDAQ rose 0.74% to 7,962.44. The S&P also rose, ... 
Tags Mid/Afternoon Market Update LYG Diversified Banks
From Benzinga
Ra Pharma Stock Doubles On $2.5B Buyout Deal With Belgian Biopharma UCB
Ra Pharmaceuticals Inc (NASDAQ: RARX) shares were up 100% Thursday following the announcement of a buyout by Belgian biopharma UCB SA ... 
Tags M&A Trading Ideas News
From Benzinga
35 Stocks Moving In Thursday's Mid-Day Session
Gainers Ra Pharmaceuticals, Inc. (NASDAQ: RARX) shares jumped 101.1% to $45.63 after the company announced it will be acquired by ... 
Tags Trading Ideas FCX RUHN
From Benzinga
Mid-Day Market Update: Dow Jumps Over 200 Points; PG&E Shares Plummet
Midway through trading Thursday, the Dow traded up 0.86% to 26,573.16 while the NASDAQ rose 0.92% to 7,976.06. The S&P also rose, ... 
Tags Eurozone Intraday Update RARX
From Benzinga
Why Ra Pharmaceuticals Is Skyrocketing Today
Shares make a triple-digit jump after the company announces that it has agreed to be acquired. Here's what investors need to know. 
Tags RARX Market News UCBJF
From Motley Fool
Stocks That Hit 52-Week Highs On Thursday
Before 10 am on Thursday, 51 stocks hit new 52-week highs. Intriguing Points: Apple (NASDAQ: AAPL) was the largest company by ... 
Tags TER AZRH IGEN
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Delta Air Lines Earnings Top Views
Following the market opening Thursday, the Dow traded up 0.55% to 26491.96 while the NASDAQ rose 0.56% to 7947.93. The S&P also ... 
Tags Market News PCG Benzinga
From Benzinga
UCB Acquires RA Pharmaceuticals For $48 Per Share In Cash or $2.1B
CB and Ra Pharmaceuticals announced their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.